Physician profile
Eric Schmidt
NPI 1922035773
$7,639.96
in general payments reported to CMS, 2019-2025
17 companies · $2,326 in 2025
The $2,326 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $37.88 · 2021: $74.69 · 2022: $664 · 2023: $760 · 2024: $3,481 · 2025: $2,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $2,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $2,066.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $5,319.72 | 2022-2025 | Ffrct |
| Abbott Laboratories | $503.10 | 2019-2025 | Triclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $371.45 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $254.94 | 2022-2025 | |
| Abiomed | $182.66 | 2023-2024 | Impella |
| Edwards Lifesciences Corporation | $170.29 | 2025 | Evoque |
| Cvrx, INC. | $168.28 | 2023 | Barostim Neo System |
| Lantheus Medical Imaging, INC. | $149.99 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $127.15 | 2025 | Xiidra, Miebo |
| Kestra Medical Technology Services, INC. | $116.86 | 2022-2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $78.77 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.98 | 2019-2023 | Jardiance |
| Harrow Eye, LLC | $42.53 | 2025 | Vevye |
| Astrazeneca Pharmaceuticals Lp | $28.20 | 2019-2022 | |
| Scpharmaceuticals INC. | $23.54 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.66 | 2022 | |
| Pfizer INC. | $13.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.